Sandu Pharmaceuticals Limited schedules board meeting on May 5, 2026 to recommend dividend for FY26.
The intimation is made under SEBI LODR Regulation 29(1)(e) requirements for corporate disclosures.
Company Secretary Pratik Mhambray digitally signed the disclosure to Bombay Stock Exchange.